Molecular imaging agents for clinical positron emission tomography in oncology other than fluorodeoxyglucose (FDG): applications, limitations and potential.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques

Volumn 10, Issue 2, 2007, Pages 180-202

  Mercer, John R ^a  

^a CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ANIMAL; HUMAN; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCINTISCANNING;

ANIMALS; FLUORODEOXYGLUCOSE F18; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 34848881371     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Review

References (125)